covid 19 News and Research

RSS

COVID-19 may provoke IgA-associated vasculitis

In a new study, scientists showed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provokes immunoglobulin A (IgA)-associated vasculitis (IgAV).

30 Aug 2022

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal antibodies (bamlanivimab/etesevimab and casirivimab/imdevimab) for the treatment of mild to moderate COVID-19 in high-risk, non-hospitalized patients.

30 Aug 2022

Disrupting a virus’s genome packaging can halt replication, study finds

Like savvy international travelers, viruses know exactly how to pack. With the genetic instructions for the next generation folded just so, snuggled into a custom-made outer covering studded with cell-grabbing proteins, these tiny invaders quest for new digs on the reg.

30 Aug 2022

Researchers review sexual well-being during the SARS-CoV-2 pandemic

Researchers conducted a scoping review on sexual well-being during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

30 Aug 2022

Relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir treatment

Researchers reported rapid relapse of COVID-19 symptoms following the administration of nirmatrelvir/ritonavir in adults.

30 Aug 2022

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

In a new study, researchers analyzed the influence of multiple shots of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Wuhan strain vaccinations on the Omicron variant.

30 Aug 2022

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

Researchers assessed the impact of SARS-CoV-2 ORF-6 on innate immune signaling.

30 Aug 2022

UK survey reveals outlook of the public towards health information circulating during the 2022 monkeypox virus outbreak

In new research, researchers explored the understanding and acceptance of public health messages about the monkeypox virus (MPXV) in the United Kingdom (UK).

30 Aug 2022

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

Researchers performed a structural bioinformatics analysis to evaluate the binding energy of the SARS-CoV-2 Omicron variants of concern spike protein receptor-binding domain to human angiotensin-converting enzyme 2 receptor compared to other VOCs.

30 Aug 2022

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

In this interview, we speak to Morteza Sarmadi from MIT about his labs latest research that developed microparticles able to deliver self-boosting vaccines.

30 Aug 2022

Outlook towards Monkeypox vaccination in healthcare workers of France and Belgium

In a new study, researchers performed a cross-sectional study to evaluate the outlook of healthcare workers (HCWs) of France and Belgium towards Monkeypox virus (MPXV) vaccination.

30 Aug 2022

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers explored the activity of an ACE2 decoy against SARS-CoV-2 Omicron variant.

30 Aug 2022

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

A new study explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for developing broad-range pan-coronavirus vaccines.

30 Aug 2022

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Researchers found proof of negative repercussions of immune history in SARS-CoV-2 infection.

30 Aug 2022

Risk factors among pregnant and postpartum women with COVID-19

Researchers investigated the clinical risk factors associated with adverse outcomes among COVID-19-infected women during pregnancy and postpartum.

30 Aug 2022

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Researchers explored the molecular and cellular mechanisms of SARS-CoV-2 infection.

30 Aug 2022

mRNA COVID boosters are effective against severe Omicron for at least six months

A new study published in the journal JAMA Network Open aimed to analyze the association of the types of vaccine and their combination with the waning of protection against Omicron in residents of Singapore who were aged 30 years and above and had received at least two doses of a COVID vaccine.

30 Aug 2022

Understanding the support programs for pregnant and postpartum people at U.S. state prisons

Published in the Journal of Criminal Justice, researchers from the University of Minnesota Medical School examined the variation of support programs for pregnant and postpartum people at six state prisons in the U.S.

29 Aug 2022

Monkeypox virus detected on household items

The CDC study describes how the monkeypox virus spreads on household surfaces.

29 Aug 2022

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

A new study conducted by the National Institutes of Health (NIH) RECOVER Pediatric Electronic Health Records (EHR) Cohort and authored by Suchitra Rao, MD, infectious disease specialist at Children's Hospital Colorado, found that the risk of post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID, in children appears to be lower than what has been reported in adults.

29 Aug 2022

covid 19 News and Research

COVID-19 may provoke IgA-associated vasculitis

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Disrupting a virus’s genome packaging can halt replication, study finds

Researchers review sexual well-being during the SARS-CoV-2 pandemic

Relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir treatment

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

UK survey reveals outlook of the public towards health information circulating during the 2022 monkeypox virus outbreak

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

Outlook towards Monkeypox vaccination in healthcare workers of France and Belgium

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Risk factors among pregnant and postpartum women with COVID-19

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

mRNA COVID boosters are effective against severe Omicron for at least six months

Understanding the support programs for pregnant and postpartum people at U.S. state prisons

Monkeypox virus detected on household items

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News